证券记录 · 已归档季度
AMGN
Amgen Inc. · Healthcare · Drug Manufacturers - General
19被追踪持有人
-1Δ持有人
39.65M持有股份
$12.76B报告持仓市值
+1新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -5.0% ·
股份流向 +0.2% ·
净新建仓位 -5.3%
· 公式
集中增持：持股数量上升，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 1.52M | $603.13M | n/a | −2 |
| Q2 2026 | 169 | -1 | 364.70M | $131.99B | +5 | −7 |
| Q1 2026 | 174 | -2 | 366.40M | $128.82B | +4 | −7 |
| Q4 2025 | 175 | 0 | 394.29M | $128.98B | +2 | −1 |
| Q3 2025 | 26 | 0 | 206.42M | $58.23B | n/a | −1 |
| Q2 2025 | 24 | +1 | 183.25M | $51.15B | +2 | −1 |
| Q1 2025 | 20 | -2 | 81.79M | $25.47B | n/a | −2 |
| Q4 2024 | 22 | +2 | 74.78M | $19.48B | +2 | n/a |
| Q3 2024 | 19 | -1 | 39.65M | $12.76B | +1 | −2 |
| Q2 2024 | 20 | n/a | 39.58M | $12.36B | n/a | n/a |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | PRIMECAP Management ✦ | 14.26M | -1.3% | $4.59B | 3.4% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 12.12M | +0.9% | $3.89B | 0.3% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (被动) | 5.80M | -0.1% | $1.87B | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 4.55M | +0.6% | $1.46B | 0.2% | ▲ Add | 2 | SEC ↗ ×2 |
| 5 | Marshall Wace ✦ | 705.11K | +7.4% | $227.19M | 0.3% | ▲ Add | 2 | SEC ↗ ×2 |
| 6 | Adage Capital Partners ✦ | 601.66K | +4.0% | $193.86M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 7 | Capital World Investors ✦ | 466.65K | 新增 | $150.36M | 0.0% | New | 1 | SEC ↗ |
| 8 | Two Sigma Investments ✦ | 358.74K | -33.8% | $115.59M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 239.35K | +2.1% | $77.12M | 0.0% | ▲ Add | 2 | SEC ↗ ×8 |
| 10 | D. E. Shaw & Co. ✦ | 166.45K | -45.7% | $53.63M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 120.74K | +65.1% | $38.75M | 0.1% | ▲ Add | 2 | SEC ↗ ×3 |
| 12 | Fisher Asset Management ✦ | 102.35K | +21.3% | $32.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | ARK Investment Management ✦ | 76.61K | +2.4% | $24.69M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 14 | Millennium Management ✦ | 30.01K | -55.3% | $9.67M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 21.41K | -3.3% | $6.90M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 16 | Dodge & Cox ✦ | 14.28K | -0.7% | $4.60M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 7.80K | -65.8% | $2.51M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | GAMCO Investors ✦ | 5.25K | -6.2% | $1.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 3.37K | -61.4% | $1.09M | 0.0% | ▼ Trim | 2 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Capital World Investors | $150.36M | 0.0% |
已清仓
| Renaissance Technologies | $16.32M | 曾为 0.0% |
| Arrowstreet Capital | $11.65M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 3,100 持有人, 420.54M 股份, $144.29B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 13
Khosla Rachna
Officer · 1.25K 股 · $521,365
Aug 11
Khosla Rachna
Officer · 2.00K 股 · $825,134
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据